Key facts
- This page summarizes Lawrence Lamb's Form 4 filing for IN8BIO, INC. (INAB).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 12 May 2026, 16:30.
Lawrence Lamb - 09 May 2026 Form 4 Insider Report for IN8BIO, INC. (INAB)
- Reporting relationship
- EVP and CSO
- Issuer ticker
- INAB
- Reported as of
- 09 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 May 2026, 16:30:23 UTC
- Prior SEC filing
- 06 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ William Ho, Attoney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Lawrence Lamb filed Form 4 for IN8BIO, INC. (INAB) on 12 May 2026.
Change
- Previous filing in this sequence was filed on 06 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001830059
Primary reporting owner
Lamb Lawrence
- Relationship
- EVP and CSO
- Address
- C/O IN8BIO, INC., 350 5TH AVE. SUITE 5330, NEW YORK
- Signature
- /s/ William Ho, Attoney-in-Fact
- Signature date
- 12 May 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INAB
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- Shares
- +54,000
- Change %
- Price
- $0.000000*
- Shares after
- 54,000
- Date
- 09 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 54,000
- Exercise price
- $1.58
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Twenty-five percent (25%) of the shares subject to the option shall vest on each of November 9, 2026, May 9, 2027, November 9, 2027 and May 9, 2028, subject to the Reporting Person continuing to provide service through each such date.